{"id":"W2883590012","doi":"10.1136/annrheumdis-2018-eular.5825","title":"AB0912 Two-year efficacy and safety of guselkumab for treatment of moderate-to-severe psoriasis: phase 3 voyage 1 trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Clinical trial; Phase (matter); Dermatology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001949461,0.001622577,0.003890124,0.0004088808,0.0006295132,0.001879138,0.001372112,0.00228794,0.005591527],"category_scores_gemma":[0.001045939,0.0006586036,0.002815288,0.0003998225,0.001072133,0.001517334,0.0004670731,0.006175558,0.002155015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007649561,"about_ca_system_score_gemma":0.001023595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008919018,"about_ca_topic_score_gemma":0.001649935,"domain_scores_codex":[0.9993281,0.0002629232,0.00003007924,0.0001037251,0.00006095495,0.000214202],"domain_scores_gemma":[0.9991277,0.000189532,0.0001385345,0.0001020035,0.00004772331,0.0003944793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8845531,0.01764333,0.001725439,0.00083155,0.001881224,0.0001250805,0.0001276724,0.001170602,0.01420647,0.0002564953,0.003790024,0.07368912],"study_design_scores_gemma":[0.8403631,0.1438079,0.01005957,0.00008165198,0.00072431,0.0001757215,0.00005310641,0.0007490245,0.001469781,0.0003300792,0.002130094,0.00005560555],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825009,0.009106499,0.0005533224,0.001228724,0.0005116313,0.001127532,0.001998502,0.000258773,0.002714121],"genre_scores_gemma":[0.9814848,0.004543866,0.001179387,0.002433754,0.0003987299,0.001582589,0.003264228,0.00008447784,0.00502815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005591527,"threshold_uncertainty_score":0.01870555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1387671470862311,"score_gpt":0.4467224896793756,"score_spread":0.3079553425931446,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}